A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Loteprednol etabonate
Dexetimide
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.
Loteprednol etabonate
Aclidinium
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Aclidinium.
Loteprednol etabonate
Dimetindene
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.
Loteprednol etabonate
Hexocyclium
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.
Loteprednol etabonate
Mepenzolate
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.
Loteprednol etabonate
Isopropamide
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.
Loteprednol etabonate
Diphenidol
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Diphenidol.
Loteprednol etabonate
Flavoxate
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Loteprednol etabonate
Glycopyrronium
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Loteprednol etabonate
Cycrimine
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Cycrimine.
Loteprednol etabonate
Methantheline
St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Methantheline.
Loteprednol etabonate
Methylene blue
St. John's Wort may increase the serotonergic activities of Methylene blue.
Loteprednol etabonate
Lumacaftor
The serum concentration of St. John's Wort can be decreased when it is combined with Lumacaftor.
Loteprednol etabonate
Indalpine
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Indalpine.
Loteprednol etabonate
Desvenlafaxine
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Desvenlafaxine.
Loteprednol etabonate
Dapoxetine
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Dapoxetine.
Loteprednol etabonate
Sibutramine
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Sibutramine.
Loteprednol etabonate
Alaproclate
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Alaproclate.
Loteprednol etabonate
Ritanserin
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Ritanserin.
Loteprednol etabonate
Seproxetine
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Seproxetine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3